Laurence A. Turka serves as Executive at Rubius Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Laurence A. Turka has executed 5 insider transactions totaling $17.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 31, 2023 involved selling 2,593 shares valued at $622.
Laurence A. Turka currently holds 18,391 shares of Rubius Therapeutics, Inc. (RUBY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Laurence A. Turka has been a net seller of RUBY stock. They have purchased $0 and sold $17.2K worth of shares.
Laurence A. Turka's most recent insider trade was on Jan 31, 2023, when they sold 2,593 shares at $0.24 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 29, 2023 | RUBY | $0 | Option Exercise | 7,438 | $N/A | Discretionary |
| Feb 1, 2022 | RUBY | $16.5K | Sale | 2,517 | $6.57 | Discretionary |
| Jan 29, 2022 | RUBY | $0 | Option Exercise | 7,438 | $N/A | Discretionary |